CONTENTS
Cover
Title Page
Copyright
Dedication
Intro
1. Missing Data
2. Where Do New Drugs Come From?
3. Bad Regulators
4. Bad Trials
5. Bigger, Simpler Trials
6. Marketing
Conclusion: Better Data
Afterword: What Happened Next?
Footnotes
Notes
Glossary
Acknowledgements, Further Reading and a Note on Errors
By the Same Author
About the Author
About the Publisher
